In this GEN webinar, Alex Zevin, PhD, director of Fred Hutchinson Cancer Center’s Genomics Shared Resource, draws on hands-on experience with managing a suite of nucleic acid quantification ...

Asymptomatic and pre-symptomatic individuals primarily drive the coronavirus disease 2019 (COVID-19) pandemic by unknowingly transmitting the virus to others. Asymptomatics are those infected people ...

Add Yahoo as a preferred source to see more of our stories on Google. For any American wondering if they have Covid-19, there are two kinds of tests available: polymerase chain reaction (PCR) and ...

PCR technology is a molecular diagnostics technology that detects target nucleic acids by amplifying the DNA amount. It has brought marked progress in the life sciences field since its development in ...

QIAGEN N.V. QGEN recently announced the launch of three new kits for use on its QIAcuity systems and a major new software update. These are designed to expand the portfolio of applications for the use ...

SALT LAKE CITY--(BUSINESS WIRE)--Molecular diagnostics company XCR Diagnostics has been awarded a patent by the United States Patent and Trademark Office for its technology that speeds up the testing ...

Expands Aegea Biotechnologies' Intellectual Property for Methods of Detecting Rare Genetic Events and for Methods to Improve PCR Amplification Reactions; Applicable to Coronavirus (COVID-19) Molecular ...

Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced the United States Patent and Trademark Office has issued U.S. Patent No.